CA2544460A1 - Controlled-release biocompatible ocular drug delivery implant devices and methods - Google Patents
Controlled-release biocompatible ocular drug delivery implant devices and methods Download PDFInfo
- Publication number
- CA2544460A1 CA2544460A1 CA002544460A CA2544460A CA2544460A1 CA 2544460 A1 CA2544460 A1 CA 2544460A1 CA 002544460 A CA002544460 A CA 002544460A CA 2544460 A CA2544460 A CA 2544460A CA 2544460 A1 CA2544460 A1 CA 2544460A1
- Authority
- CA
- Canada
- Prior art keywords
- methods
- devices
- controlled
- release
- drug delivery
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Granted
Links
Abstract
Controlled release devices are disclosed which are biocompatible and can be implanted into the eye. The devices have a core comprising a drug and a polymeric outer layer which is substantially impermeable to the entrance of an environmental fluid and substantially impermeable to the release of the drug during a delivery period, and drug release is affected through an orifice in the outer layer. These devices have an orifice area of less than 10 % of the total surface area of the device and can be used to deliver a variety of drugs with varying degrees of solubility and or molecular weight. Methods are also provided for using these drugs delivery devices.
Applications Claiming Priority (3)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US09/426,141 US6331313B1 (en) | 1999-10-22 | 1999-10-22 | Controlled-release biocompatible ocular drug delivery implant devices and methods |
US09/426,141 | 1999-10-22 | ||
CA002355313A CA2355313C (en) | 1999-10-22 | 2000-10-19 | Controlled-release biocompatible ocular drug delivery implant devices and methods |
Related Parent Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
CA002355313A Division CA2355313C (en) | 1999-10-22 | 2000-10-19 | Controlled-release biocompatible ocular drug delivery implant devices and methods |
Publications (2)
Publication Number | Publication Date |
---|---|
CA2544460A1 true CA2544460A1 (en) | 2001-05-03 |
CA2544460C CA2544460C (en) | 2009-04-07 |
Family
ID=36702811
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
CA002544460A Expired - Lifetime CA2544460C (en) | 1999-10-22 | 2000-10-19 | Controlled-release biocompatible ocular drug delivery implant devices and methods |
Country Status (1)
Country | Link |
---|---|
CA (1) | CA2544460C (en) |
Cited By (4)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
WO2011079232A1 (en) * | 2009-12-23 | 2011-06-30 | Psivida Us, Inc. | Sustained release delivery devices |
US8252307B2 (en) | 1999-03-22 | 2012-08-28 | Psivida Us, Inc. | Method for treating and/or preventing retinal diseases with sustained release corticosteroids |
US8574613B2 (en) | 2000-04-26 | 2013-11-05 | Psivida Us, Inc. | Sustained release drug delivery devices, methods of use, and methods of manufacturing thereof |
US8871241B2 (en) | 2002-05-07 | 2014-10-28 | Psivida Us, Inc. | Injectable sustained release delivery devices |
-
2000
- 2000-10-19 CA CA002544460A patent/CA2544460C/en not_active Expired - Lifetime
Cited By (7)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US8252307B2 (en) | 1999-03-22 | 2012-08-28 | Psivida Us, Inc. | Method for treating and/or preventing retinal diseases with sustained release corticosteroids |
US8574613B2 (en) | 2000-04-26 | 2013-11-05 | Psivida Us, Inc. | Sustained release drug delivery devices, methods of use, and methods of manufacturing thereof |
US8574659B2 (en) | 2000-04-26 | 2013-11-05 | Psivida Us, Inc. | Sustained release drug delivery devices, methods of use, and methods of manufacturing thereof |
US9192579B2 (en) | 2000-04-26 | 2015-11-24 | Psivida Us, Inc. | Sustained release drug delivery devices, methods of use, and methods of manufacturing thereof |
US9849085B2 (en) | 2000-04-26 | 2017-12-26 | Psivida Us Inc. | Sustained release drug delivery devices, methods of use, and methods of manufacturing thereof |
US8871241B2 (en) | 2002-05-07 | 2014-10-28 | Psivida Us, Inc. | Injectable sustained release delivery devices |
WO2011079232A1 (en) * | 2009-12-23 | 2011-06-30 | Psivida Us, Inc. | Sustained release delivery devices |
Also Published As
Publication number | Publication date |
---|---|
CA2544460C (en) | 2009-04-07 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
CA2355313A1 (en) | Controlled-release biocompatible ocular drug delivery implant devices and methods | |
US4898733A (en) | Layered, compression molded device for the sustained release of a beneficial agent | |
WO2005013936A3 (en) | Manufacture of long term drug delivery devices with polyurethane based polymers | |
CA2230947A1 (en) | Implantable controlled release device to deliver drugs directly to an internal portion of the body | |
WO2001043749A3 (en) | Pharmaceutical implant containing immediate-release and sustained-release components and method of administration | |
WO2002049535A3 (en) | Medicated polymer-coated stent assembly | |
CA2395077A1 (en) | Liquid composition of biodegradable block copolymer for drug delivery system and process for the preparation thereof | |
CA2531833A1 (en) | Poly-4-hydroxybutyrate matrices for sustained drug delivery | |
CA2395333A1 (en) | Hydrogel-driven drug dosage form | |
CA2367209A1 (en) | Stent security balloon/balloon cathether | |
CA2375714A1 (en) | Delayed total release two pulse gastrointestinal drug delivery system | |
CA2383499A1 (en) | Drug delivery device | |
CA2305762A1 (en) | Delayed total release gastrointestinal drug delivery system | |
WO2001008717A9 (en) | Controlled release implantable devices | |
WO2002047731A3 (en) | Drug delivery compositions and coated medical devices | |
WO2002011702A3 (en) | Hydrogel-driven drug dosage form | |
ATE554806T1 (en) | DEVICE FOR DELIVERING THERAPEUTIC AGENTS HAVING A SEPARATING PROTECTIVE LAYER | |
WO2005115493A3 (en) | Thermal treatment of an implantable medical device | |
MY133883A (en) | Gastrointestinal drug delivery system | |
WO2005025634A3 (en) | Biointerface membranes incorporating bioactive agents | |
EP1125577A3 (en) | Liquid drug delivery compositions | |
CA2513751A1 (en) | Sustained release device and method for ocular delivery of adrenergic agents | |
AU2001291526A1 (en) | Sustained release composition containing clarithromycin | |
WO2005065643A3 (en) | Sutureless ophthalmic drug delivery system and method | |
CA2340898A1 (en) | Compositions and methods for treating intracellular infections |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
EEER | Examination request | ||
MKEX | Expiry |
Effective date: 20201019 |